Overall, these results suggest that through an ER-dependent mechanism, E2 may increase mitochondrial ROS production by repressing UCPs, which offers a new perspective on the understanding of why E2 is a risk factor for breast cancer. The gene discussed is ESR1; the disease is breast cancer.